Cargando…

Osteosarcoma: Evolution of Treatment Paradigms

This paper reviews the contribution of chemotherapy in the conquest of osteosarcoma. It discusses how the treatment of osteosarcoma has evolved over the last five decades, resulting in a more than fivefold increase in survival. Though the initial improvements in survival were dramatic, essentially t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaffe, Norman, Puri, Ajay, Gelderblom, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678494/
https://www.ncbi.nlm.nih.gov/pubmed/23781130
http://dx.doi.org/10.1155/2013/203531
_version_ 1782272864546717696
author Jaffe, Norman
Puri, Ajay
Gelderblom, Hans
author_facet Jaffe, Norman
Puri, Ajay
Gelderblom, Hans
author_sort Jaffe, Norman
collection PubMed
description This paper reviews the contribution of chemotherapy in the conquest of osteosarcoma. It discusses how the treatment of osteosarcoma has evolved over the last five decades, resulting in a more than fivefold increase in survival. Though the initial improvements in survival were dramatic, essentially there has been no change in the outlook for this disease over the past 30 years. The paper also highlights the necessity of a multidisciplinary approach to combat this disease and stresses the need to explore newer treatment agents in order to build on the lessons learnt from the past while striving to achieve greater levels of success.
format Online
Article
Text
id pubmed-3678494
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36784942013-06-18 Osteosarcoma: Evolution of Treatment Paradigms Jaffe, Norman Puri, Ajay Gelderblom, Hans Sarcoma Review Article This paper reviews the contribution of chemotherapy in the conquest of osteosarcoma. It discusses how the treatment of osteosarcoma has evolved over the last five decades, resulting in a more than fivefold increase in survival. Though the initial improvements in survival were dramatic, essentially there has been no change in the outlook for this disease over the past 30 years. The paper also highlights the necessity of a multidisciplinary approach to combat this disease and stresses the need to explore newer treatment agents in order to build on the lessons learnt from the past while striving to achieve greater levels of success. Hindawi Publishing Corporation 2013 2013-05-27 /pmc/articles/PMC3678494/ /pubmed/23781130 http://dx.doi.org/10.1155/2013/203531 Text en Copyright © 2013 Norman Jaffe et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Jaffe, Norman
Puri, Ajay
Gelderblom, Hans
Osteosarcoma: Evolution of Treatment Paradigms
title Osteosarcoma: Evolution of Treatment Paradigms
title_full Osteosarcoma: Evolution of Treatment Paradigms
title_fullStr Osteosarcoma: Evolution of Treatment Paradigms
title_full_unstemmed Osteosarcoma: Evolution of Treatment Paradigms
title_short Osteosarcoma: Evolution of Treatment Paradigms
title_sort osteosarcoma: evolution of treatment paradigms
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678494/
https://www.ncbi.nlm.nih.gov/pubmed/23781130
http://dx.doi.org/10.1155/2013/203531
work_keys_str_mv AT jaffenorman osteosarcomaevolutionoftreatmentparadigms
AT puriajay osteosarcomaevolutionoftreatmentparadigms
AT gelderblomhans osteosarcomaevolutionoftreatmentparadigms